Log In
Print
BCIQ
Print
Print this Print this
 

Somatoprim (DG3173)

  Manage Alerts
Collapse Summary General Information
Company Aspireo Pharmaceuticals Ltd.
DescriptionSomatostatin analog that suppresses human growth hormone (hGH) secretion by targeting somatostatin receptors 2, 4 and 5
Molecular Target Somatostatin receptor 2 (SSTR2) ; Somatostatin receptor 4 (SSTR4)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today